openPR Logo
Press release

Investigation announced for Investors in shares of Viewray Inc (NASDAQ: VRAY)

09-10-2019 05:48 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Viewray Inc (NASDAQ: VRAY) shares over potential wrongdoing at Viewray Inc.

An investigation on behalf of investors in Viewray Inc (NASDAQ: VRAY) shares over potential wrongdoing at Viewray Inc.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Viewray Inc.

Investors who purchased shares of Viewray Inc (NASDAQ: VRAY) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Viewray Inc directors breached their fiduciary duties and caused damage to the company and its shareholders.

Oakwood Village, OH based ViewRay, Inc. designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously.

On May 2, 2019, ViewRay, Inc. announced financial results for the first quarter ended March 31, 2019. The Company reported a loss of $0.34 per share while analysts were expecting a per share loss of $0.22.
Then, on August 8, 2019, ViewRay, Inc.announced financial results for the second quarter ended June 30, 2019. ViewRay reported a quarterly loss of $0.32 per share versus analyst estimates of a loss of $0.23.

Shares of Viewray Inc (NASDAQ: VRAY) declined from $8.51 per share on August 5, 2019 to as low as $2.76 per share on August 9, 2019.

Those who purchased shares of Viewray Inc (NASDAQ: VRAY), have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Viewray Inc (NASDAQ: VRAY) here

News-ID: 1831692 • Views: 472

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors in shares of Hecla Mining Compan …
An investigation was announced for investors in shares of Hecla Mining Company (NYSE: HL) concerning potential breaches of fiduciary duties by certain directors and officers of Hecla Mining Company. Investors who are current long term investors in Hecla Mining Company (NYSE: HL) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors
Investigation announced for Investors in Sasol Limited (NYSE: SSL) shares over p …
Sasol Limited is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Sasol Limited (NYSE: SSL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Sasol Limited (NYSE: SSL regarding its business, its prospects and its operations were materially false and
Lawsuit filed for Investors in shares of MacroGenics, Inc. (NASDAQ: MGNX)
An investor, who purchased shares of MacroGenics, Inc. (NASDAQ: MGNX), filed a lawsuit over alleged violations of Federal Securities Laws by MacroGenics, Inc.. Investors who purchased shares of MacroGenics, Inc. (NASDAQ: MGNX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 12, 2019. NASDAQ: MGNX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Rockvillem MD based MacroGenics, Inc., a biopharmaceutical
Investigation announced for Investors in shares of The RealReal, Inc. (NASDAQ: R …
An investigation was announced concerning potential securities laws violations by The RealReal, Inc. in connection with certain financial statements was announced. Investors who purchased shares of The RealReal, Inc. (NASDAQ: REAL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by The RealReal, Inc. regarding its business, its prospects and its

All 5 Releases


More Releases for Viewray

MRI-guided Radiation Therapy System Market Key Players Insights - ViewRay Inc, E …
MRI-guided Radiation Therapy System Market Insights Radiation therapy is evolving with new technologies and techniques. Most of these new methods are focused on maximizing the dose to the tumor site and protecting the surrounding tissue. Image guided radiation therapy offers dose distribution accuracy along with real-time treatment effect. CT-guided radiation treatment is one such image-guided radiation therapy system. However, this requires repeated exposure to X-rays, and has a relatively poor contrast
Image Guided Radiotherapy Market 2019- 2023 by ViewRay, General Electric Company …
Image Guided Radiotherapy or IGRT is a type of conformal radiotherapy involving the use of different scans and X-rays to treat a specific area of cancer growth. Image-guided radiation therapy integrated with a technique called intensity-modulated radiotherapy (IMRT), enables to shape the radiation beam to the outline of tumors in real time, even as they move in the body. This treatment targets tumors with pinpoint accuracy, and minimize the side-effects
Global Image Guided Radiation Therapy (IGRT) Market Revenue Status & Forecast Re …
The recent published research report sheds light on critical aspects of the global Image Guided Radiation Therapy (IGRT) market such as vendor landscape, competitive strategies, market drivers and challenges along with the regional analysis. The report helps the readers to draw a suitable conclusion and clearly understand the current and future scenario and trends of global Image Guided Radiation Therapy (IGRT) market. The research study comes out as a compilation
Radiotherapy Market worth $6.8 billion by 2023 | Varian Medical Systems, Inc. (U …
The report "Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User (Hospital) - Forecasts to 2023", The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1% Browse 150 market data Tables and 46 Figures spread through 226 Pages and in-depth
Treatment Planning Software Market Key Players Accuray Incorporated, RaySearch L …
Global Treatment Planning Software Market: Overview The revolutionary changes in the healthcare sector due to the increasing penetration of information technology, the patient treatment programs are also changing along with the treatment delivery ways for doctors. With this rapid technology adoption, the treatment planning software is standing out as the heart of radiation therapy. Increasing number of cancer patients the global level are leading to the increasing demand of the treatment
Image Guided Radiotherapy Market Is Expected To Grow At an Approximate CAGR Of 1 …
Global Imaging Guided Radiotherapy Market - Key Players Some of the key players in The Imaging Guided Radiotherapy Market are ViewRay (US), General Electric Company (US), Hitachi, Ltd. (Japan), Siemens AG (Germany), Koninklijke Philips N.V. (Netherland), TOSHIBA CORPORATION (Japan), Varian Medical Systems, Inc. (US), Vision RT Ltd. (UK), Scranton Gillette Communications (US), XinRay Systems (US), and C-RAD (Sweden). Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4276 Global Imaging Guided Radiotherapy Market - Industry Updates Nov, 2017 ViewRay,